Open Access<p>High Serum Neuron-Specific Enolase Level Is Associated with Mild Cognitive Impairment in Patients with Diabetic Retinopathy</p>
Author(s) -
Zi-Wei Yu,
Rong Liu,
Xin Li,
Ying Wang,
Yuhong Fu,
Hui-Yao Li,
Yue Yuan,
Xinyuan Gao
Publication year - 2020
Publication title -
diabetes, metabolic syndrome and obesity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.853
H-Index - 43
ISSN - 1178-7007
DOI - 10.2147/dmso.s249126
Subject(s) - enolase , medicine , confounding , biomarker , receiver operating characteristic , diabetic retinopathy , cognitive impairment , cognition , mini–mental state examination , gastroenterology , diabetes mellitus , endocrinology , psychiatry , disease , biochemistry , chemistry , immunohistochemistry
Diabetic retinopathy (DR) can increase the risk of mild cognitive impairment (MCI), which has been confirmed by previous researches. With the frequent occurrence of MCI in patients with DR, the early detection of MCI has become a research hot-spot. The aim of this study was to investigate the relationship between neuron-specific enolase (NSE) and MCI in patients with DR.